Abstract. A variety of pharmaceutical agents has been proposed for use in periodontal therapy to inhibit loss of alveolar bone and to promote regeneration of tissues lost to disease. The purpose of this study was to determine the effects of such agents on periodontal cell-mediated gel contraction, an in vitro process considered representative of wound contraction and remodeling in vivo. Human gingival fibroblasts were cultured in a type I collagen lattice, and contraction was quantified by means of a computer-assisted video imaging system. Cell-gel combinations were prepared with cells both pre-exposed and non-exposed to agents; non-anchored cell-gels were then incubated with agents for various time periods. Agents tested included Demecolcine (an inhibitor of cytoskeletal contraction), growth factors (i.e., TGF-,1, PDGF, and IGF-1), and non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin, ibuprofen, naproxen, and flurbiprofen). While Demecolcine inhibited gel contraction, TGF-31 (1-20 ng/mL), PDGF (100 ng/mL), IGF-1 (1000 ng/mL), and [PDGF + IGF], all of which have been reported to enhance wound healing in vivo, promoted lattice contraction in this system. In contrast, NSAIDs inhibited cell-gel contraction. Ethanol, used to solubilize two specific NSAIDs, also inhibited cell proliferation and gel contractile ability, even at very low concentrations. These findings indicate that periodontal cells respond differently to various agents in vitro and may be adversely affected by alcohol. Furthermore, the results of this study suggest that the cell-lattice contraction system holds potential as a method for screening agents for positive or negative effects on cell activity.
Introduction
There is a general agreement that periodontal tissues lost as a consequence of disease can be restored, at least in part (Aukhil et al., 1990) . Such regeneration requires the formation of both mineralized and soft connective tissues. According to current evidence, these tissues are formed by cells derived from the remaining healthy portions of periodontal tissues including the periodontal ligament and/or the endosteal spaces of alveolar bone (Aukhil et al., 1990; McCulloch, 1993) . To form new tissues, these progenitor cells undergo a series of important biological events which most likely include migration, attachment to a substratum, proliferation, and differentiation (MacNeil and Somerman, 1993) . The recognition that these processes occur during regenerative healing has resulted in efforts to identify and develop agents capable of promoting such events.
Most research directed at evaluating agents for use in treatment of periodontal diseases typically involve higherorder animals and humans. These studies have included evaluation of agents for their ability to alter microflora (Kornman et al., 1990) , to reduce attachment loss (Offenbacher et al., 1992; Heasman et al., 1993) , to foster new attachment formation, and/or to induce regeneration (see review : Caffesse et al., 1993) . The development of in vitro models that can be used to screen agents prior to the initiation of animal or human clinical trials will decrease cost and time of product development and may reduce the need for animal experimentation, especially in situations where screening indicates that an agent has limited utility. Importantly, reliable screening models may also increase the success rate of clinical trials.
A variety of cells, nutrients, and factors has been assembled within collagen gels, in vitro, in attempts to develop a model more closely resembling an in vivo system when compared with monolayer cell culture (Montesano and Orci, 1988; Tomasek et al., 1992; Hoffman, 1993; Huang et al., 1993) . The cell-collagen gel system is based on the principle that, under normal conditions, fibroblasts suspended in a collagen matrix reduce the matrix and remodel the gel to form a tissueequivalent material. This process is considered to be 903 representative of Wound repair and remodeling i/l vivy (Bell ct A)., 1979; Ehrlich and White, 1983) . Contraction and remodeling are regulated by cell attachment to the extracellular matrix and resulting traction force mediated by specific cellular proteins (Huang ct al., 1993; Lee ct al., 1993 
Materials and methods

Cell culture
The methods for obtaining and culturing periodontal ligament (PDLF) and gingival fibroblasts (GF) have been reported in detail (Somerman ct al., 1988 vitality staining was also performed to determine toxicity of agents. Monolayer cultures were used, since these cultures are generally more sensitive to agents (Hoffman, 1993) .
Agents
The agents used were as follows: 2% Demecolcine, a cytoskeletal inhibitor, purchased from Sigma, was prepared from a stock water base solution of 100 mg/mL. Non-steroidal anti-inflammatory agents (NSAIDs) were indomethacin, ibuprofen, naproxen, and flurbiprofen (all agents were purchased from Sigma). Indomethacin and ibuprofen were first solubilized in ethanol and then diluted from a 10 mg/mL stock solution with standard media. Because of the necessity of using ethanol in the preparation of these agents, ethanol was included as a control in related cell-gel and monolayer culture experiments. Two water-soluble NSAIDs, naproxen and flurbiprofen, were prepared by dilution with media from a stock solution of 5 mg/mL sterile water.
Growth factors, platelet-derived growth factor (PDGF-AA) and insulin growth factor-I (IGF-I), were purchased from Calbiochem (San Diego, CA) and prepared from stock solutions in water of 2 ng/mL and 50 ng/100 mL, respectively. Transforming growth factor 13 (TGF-1l), purchased from R&D Systems (Minneapolis, MN), was prepared from a 2 ng/mL solution in 4 mM HCL/1% bovine serum albumin (BSA).
Quantificationldata analysis
To determine the surface area of contracting gels, we removed gels from the incubator at designated intervals and viewed them from above using a high-resolution video camera ( 
Hours
Figures 7A and 7B. Effect of pre-incubation (A) of cells on gel contraction compared with that observed when cells were not pre-incubated (B) with flurbiprofen (Flur) prior to incorporation into gels. In both cases, 1.0 mM flurbiprofen significantly (P < 0.001; n = 3) inhibited gel contraction at all timepoints, although pre-incubation resulted in a more dramatic and sustained effect at this particular concentration. Cellgels' pre-incubation with 0.1 mM flurbiprofen also demonstrated a significant (P < 0.001; n = 3) reduction in contraction at 2 and 4 hr. No other significant differences were observed between groups.
contraction up to 4 h, while both agents at 1.0 mM concentration were inhibitory to 6 h (Figs. 6, 7A) . By 24 h, cell-gels exposed to naproxen had recovered from this initial inhibitory effect. In contrast, cells exposed to flurbiprofen were severely limited in their capacity to contract gels at all timepoints evaluated. These results were extremely reproducible, being noted in three independent experiments. Since cells pre-incubated with flurbiprofen demonstrated a sustained inhibition of contractive ability, cell-gel contraction was further assessed with cells which were not pre-treated with this agent. In the absence of a pre-incubation phase, flurbiprofen at 1.0 mM had a marked inhibitory effect on cell-gel contraction (Fig. 7B) ; however, this effect was not as remarkable as that seen following pre-incubation of cells with the drug (Fig. 7A) . To determine if flurbiprofen at dosages tested may have a cytotoxic effect, we exposed cells in monolayer cultures to flurbiprofen (0.01 mM to 1.0 mM) and monitored the proliferation rate over a seven-day period. Following short-term drug exposures comparable with those used in the cell-gel contraction assays, cell proliferation was not altered by flurbiprofen. However, by day four, cells exposed to higher concentrations of flurbiprofen (i.e., 1.0 mM) were growthinhibited when compared with untreated cells or cells treated with lower concentrations of flurbiprofen (Fig. 8) .
To determine whether these cells were still capable of proliferating, we removed flurbiprofen and cultured cells in standard media for three days. As demonstrated in Fig. 8 , gingival fibroblasts by day seven had recovered from the inhibitory effects of lower concentrations of flurbiprofen, and cell proliferation had rebounded when compared with cells exposed continuously to drug. However, cells exposed to the highest concentration of flurbiprofen (1.0 mM) continued to show reduced proliferative activity relative to controls following three days in the absence of this agent.
Growth factors
At timepoints as early as two hours, TGF-I1 enhanced gel contraction at doses ranging from 1-20 ng/mL (Fig. 9) . IGF-1 (1000 ng/mL) and PDGF (100 ng/mL) also stimulated gel contraction, with an additive effect when cells were exposed to both in combination (Figs. 1OA, lOB) .
Discussion
The two major objectives of this study were to design a cellgel system where periodontal cells promoted reproducible contraction of collagen matrices and then to assess various agents with potential application in periodontal therapy for their ability to influence cell-collagen gel contraction. During development of this model system, a variety of published methods for gel preparation and measurement was assessed; these included comparison of anchored (attached) vs. nonanchored (floating) cell-gel systems (Nakagawa et al., 1989; Grinnell, 1994 (Mochitate (t al., 1989) , and video-imaging of non-labeled gels, and comparison of gingival vs. periodontal ligament fibroblasts contractile patterns (present study). The system described here, i.c., gingival fibroblast cells cultured in nonanchored gels and measured by computer-assisted imaging, represented the most consistent and accurate method for the quantification of gel matrix contraction. Multiple replicate experiments revealed that fibroblasts derived from either human gingival connective tissue or periodontal ligament contracted gels similarly and consistently, with only minor inter-experimental variability; this contractile ability was negated by Demecolcine, a cytoskeletal inhibitor. These results are in agreement with those of previous studies which reported that various cytoskeletal antagonists inhibit cellmediated gel contraction (Kasugai and Ogura, 1993) and indicated that cells within the collagen gel were functional and responsive to exogenous agents. A particularly interesting finding was that NSAIDs and growth factors influenced gingival fibroblast-mediated gel contraction in distinctly different fashions.
Recent interest in usinig NSAIDs to control periodontal tissue destruction (Offenbacher et al., 1992; Heasman et al., 1993) prompted us to examine four specific NSAIDs formulations in the cell-gel system. In vivo, NSAIDs inhibit the production of mediators of inflammation and subsequent osteoclast activation by blocking the enzyme systems, i.e., eicosanoids, that convert arachidonic acid to individual metabolites, e.g., prostaglandins and leukotrienes. (The term "eicosanoids" refers to the Hours Figure 9 . Effect of TGF-bl on gingival-fibroblast-mediated gel contraction. TGF-IE at concentrations of 1 ng/mml. It) ig/ml and 2(0 ng/mL significantly increased gel contraction at 2 hr (P < 0.01) and all other timepoints (P < 0.001) (n = 3).
arachidonic acid cascade products and not to the enzyme systems involved in their production.) Our findinigs indicate that NSAIDs inhibit both collagen gel contraction and cell proliferation in monolayer cultures. Similar inhaibitory effects of NSAIDs on cell proliferation were reported by Nguyen and Lee (1993) , who demonstrated that fibroblasts exposed to dosages in the range of 10' to 10 4 mM exhibited a decrease in proliferation. Interestingly, in this situation, the authors concluded that the antiproliferative effect of NSAIDs may prove clinically advantageous for preventinig excessive scar formation in certain situations, i.e., postglaucoma filtration surgery. This is in contrast to the reported negative effects of NSAIDs on1 healing of duodenal ulcers, where NSAIDs are thought to inhlibit the proliferation of mucosal cells (Levi et al., 1992) .
While flurbiprofen was found to have an inhibitory effect on gingival fibroblast cell growth at four days of cell exposure, the inhibitory effect on cell-gel contraction was observed as early as 2 h (Figs. 7A, 7B ). This effect cannot be attributed to cell toxicity, since gingival fibroblasts retained a normal morphology and excluded trypan blue stain during the culture periods. One explanation for this result may lie in the demonstration that arachidonic metabolites enhance gel matrix contraction by up-regulating the expression of several integrin a-subunits (Milam et al., 1991) ; hence, the inhibitory effect observed with NSAIDs could be attributed to their anti-cyclooxygenase properties. combination had a slightly greater effect on contraction than either of these two agents alone. This combination was included since there is evidence that PDGF and IGF-1 together may have a synergistic effect on wound healing/periodontal regeneration (Lynch et al., 1991; Rutherford et al., 1993) . This synergism is thought to be related to the position in the cell cycle at which these two cytokines influence cell proliferation, i.e., PDGF is thought to function as a progressive factor, while IGF acts as a competency factor (Lynch et al., 1991) . However, it is unlikely that cell proliferation has a major influence on gel contraction in this model system, due to the relatively short time periods observed and the fact that cells in nonanchored gels have only limited proliferative activity (Grinnell, 1994) . Thus, mechanisms other than those which increase cell mitogenesis may be operative. It has been demonstrated that collagen gel contraction is dependent on activation of cytoskeletal proteins (Bell et al., 1979; Tomasek et al., 1992) , and that PDGF stimulates actin filament reorganization in monolayer cultures (Hammacher et al., 1989) . PDGF also up-regulates expression of integrin collagen receptors (p1) in rat fibroblasts cultured in threedimensional gels (Gullberg et al., 1990) . Furthermore, while IGF-1 has no known mitogenic effect on cells cultured in collagen (Gillery et al., 1992) , its addition to cell-gel cultures enhances gel contraction, an effect possibly based on its ability to stimulate collagen gene expression and protein synthesis (Gillery et al., 1992) . Collectively, these findings suggest that growth factors regulate wound healing, at least partially, via processes independent of cell proliferation.
The ability of PDGF and TGF-f1 to promote cellmediated gel contraction at doses similar to those used in this study has been reported in previous studies where a variety of cell types was used (Montesano and Orci, 1988; Clark et al., 1989; Gullberg et al., 1990; Tingstrom et al., 1992) . Several reports suggest that PDGF has a more rapid and pronounced effect on fibroblast-mediated gel contraction than TGF-P. Montesano and Orci (1988) demonstrated that gingival fibroblasts exposed to low concentrations of ethanol (2 0.0004%) were growthinhibited up to five days in culture, whereafter only higher concentrations (. 0.4% or 87 mM) continued to inhibit cell proliferation. Alcohol is known to have a dose-dependent effect on bone cells in vitro that is thought to be related to either the production of ethanol metabolites like acetaldehyde (Hurley et al., 1990) or the secondary induction of prostaglandins (Friday and Howard, 1991) . In vitro concentrations of ethanol equivalent to serum levels achieved during social drinking (from 10 to 100 mM) have also been shown to have a strong inhibitory effect on cell adhesion molecule (CAM)-mediated cell-cell adhesion in human neural cels (Charness et al., 1994) . Higher concentrations of alcohol (200 mM) exert strong inhibitory effects on DNA synthesis in murine palate cells (Weston et al., 1994) . It is currently unknown whether these cellular effects are responsible for the delayed wound-healing phenomenon observed in alcoholics. To the best of our knowledge, this is the first report of an adverse effect of alcohol on periodontal cells in vitro. Further investigations are necessary to determine the mechanisms involved and the clinical significance of this finding.
These results indicate that the cell-collagen gel contraction model holds promise as a useful tool for the study of matrix-related and cytoskeletal effects of woundhealing agents, especially those with potential utility in periodontal therapy. Importantly, because of the similarities between this in vitro system and contracting wound tissue, the fibroblast-contracted collagen lattice may represent a more tissue-equivalent construct than traditional monolayer cell cultures (Bell et al., 1979; Clark et al., 1989) . However, caution must be used in interpretation of these results. Before a bioassay can be adopted as a true screening system, sources of inherent variation-including differences in cell response based on donor profile or period within culture (e.g., number of in vitro cell divisions)-must be first assessed. In addition, it should be recognized that an agent may inhibit cell-gel contraction in vitro and wound healing in vivo, but have a distinctly positive effect on another parameter, e.g., the positive effects of NSAIDs on bone remodeling in vivo may outweigh their possible negative effects on cell proliferation and cytoskeletal proteins. Furthermore, the doses of NSAIDs used to block proliferation and other cell activities in vitro in our studies and others (Nguyen and Lee, 1993) are approximately five times the peak serum levels measured in vivo. Determination of in vitro concentrations which are representative of "real" in vivo dosages is complicated by a number of problems, including a difficulty in calculating the proportion of free vs. protein-bound molecules in these two situations. Thus, in vitro data provide important information but must be carefully interpreted, and relevance to the in vivo situation must be established.
